Wolverine Trading’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,464
Closed -$191K 5789
2024
Q3
$193K Buy
+10,464
New +$176K ﹤0.01% 4119
2023
Q3
Sell
-13,843
Closed -$165K 5020
2023
Q2
$165K Buy
13,843
+1,591
+13% +$18.1K ﹤0.01% 3600
2023
Q1
$138K Buy
+12,252
New +$152K ﹤0.01% 3573
2022
Q4
Sell
-14,018
Closed -$179K 4897
2022
Q3
$179K Buy
+14,018
New +$207K ﹤0.01% 3674
2022
Q1
Sell
-22,983
Closed -$314K 6319
2021
Q4
$313K Buy
22,983
+496
+2% +$7.02K ﹤0.01% 4088
2021
Q3
$336K Buy
+22,487
New +$380K ﹤0.01% 4539
2019
Q4
Sell
-17,906
Closed -$401K 5132
2019
Q3
$410K Buy
+17,906
New +$382K ﹤0.01% 2837

Other funds holding SBRA

Wolverine Trading's SBRA Position: Q4 2024 in Review

Wolverine Trading sold out of Sabra Healthcare REIT (SBRA) in Q4 2024, closing a stake of 10,464 shares — an estimated $191K sold.

Wolverine Trading first reported a position in SBRA in Q3 2019 and held it in 7 quarters. The position peaked at $410K in Q3 2019. 389 funds tracked by Wall St. Rank hold SBRA as of Q4 2024.

  • Wolverine Trading reported no remaining Sabra Healthcare REIT position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 10,464 Sabra Healthcare REIT shares in Q4 2024, an estimated $191K.
  • Wolverine Trading first reported a position in Sabra Healthcare REIT in Q3 2019 and held it in 7 quarters.
  • Wolverine Trading's Sabra Healthcare REIT position peaked at $410K in Q3 2019.
  • 389 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.